Xeomin(R) Data to be Presented at the 2010 American Academy of Neurology Annual Meeting in Toronto

Tuesday, April 13, 2010 General News
Email Print This Page Comment bookmark
Font : A-A+

Efficacy of NT 201 (Botulinum Neurotoxin Type A Free from Complexing Proteins) in the Treatment of Patients with Focal Dystonia

P01.268 - Poster Session I: Movement Disorders: Dystonia I, April 13, 7:30 a.m.

Safety and Efficacy of Repeated NT 201 (Botulinum Neurotoxin Type A Free from Complexing Proteins) Injections of Patients with Cervical Dystonia: A First Long-Term Safety Analysis

P01.270 - Poster Session I: Movement Disorders: Dystonia II and Tardive Dyskinesia, April 13, 7:30 a.m.

Presence of Neutralising Antibodies in a Patient Population with Cervical Dystonia Prior to Clinical Study Entry

P01.271 - Poster Session I: Movement Disorders: Dystonia II and Tardive Dyskinesia, April 13, 7:30 a.m.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook